投行公司荷兰国际集团（ING）在一项新报告中警告，由于阿斯特捷利康公司畅销药物的专利权将在未来几年中过期，公司将冒险进入“知识产权崩溃期”。
A new report from ING, an investment bank, warns that as the patents on AstraZeneca’s blockbusters expire in the coming years the firm risks going into “intellectual property meltdown”.
投行公司荷兰国际集团（ING）在一项新报告中警告，由于阿斯特捷利康公司畅销药物的专利权将在未来几年中过期，公司将冒险进入“知识产权崩溃期”。
A new report from ING, an investment bank, warns that as the patents on AstraZeneca’s blockbusters expire in the coming years the firm risks going into “intellectual property meltdown”.
应用推荐